Albert Einstein College of Medicine, Division of General Internal Medicine, Bronx, New York, USA.
Montefiore Medical Center, Division of General Internal Medicine, Bronx, New York, USA.
Subst Use Misuse. 2022;57(13):1988-1996. doi: 10.1080/10826084.2022.2125273. Epub 2022 Sep 24.
Injecting alone is a suspected risk factor for opioid overdose death among people who inject drugs (PWID). Better understanding of PWID's injecting practices and preferences could guide pragmatic harm reduction and overdose prevention interventions. We investigated injection practices and preferences among PWID attending syringe services programs (SSPs). We surveyed 108 PWID with opioid use disorder from 3 New York City SSPs between November 2020 and August 2021 to ascertain harm reduction service preferences. This secondary analysis examined injection behavior preferences, reasons for these preferences, and self-reported non-fatal lifetime overdoses. Slightly more participants preferred injecting alone (56%) than with someone present (44%), but most in both groups inject alone most of the time (97% vs 52%, p < 0.01). Commonly reported reasons for preferring to inject alone were privacy (82%) and not wanting to be judged (78%), whereas many preferred to inject with others to have someone present in case of overdose (92%), for camaraderie (69%), and to share drugs (65%). Those preferring to inject alone (vs. with someone present) self-reported higher mean number of lifetime overdoses (3.1 vs 2.6), but differences were not statistically significant. In conclusion, most participants injected alone regardless of preference. While not associated with prior non-fatal overdose, injection preference likely carries risk for future overdose. Participants preferred injecting alone to avoid shame or injecting with others in case of overdose, which can inform public health interventions that support both preferences. Reducing stigma while facilitating rapid overdose response can mitigate the risk of fatal overdose.
独自注射是药物滥用者(PWID)阿片类药物过量死亡的一个可疑风险因素。更好地了解 PWID 的注射习惯和偏好,可以指导切实可行的减少伤害和预防过量用药的干预措施。我们调查了参加注射器服务项目(SSP)的 PWID 的注射习惯和偏好。我们在 2020 年 11 月至 2021 年 8 月期间对 3 家纽约市 SSP 中的 108 名患有阿片类药物使用障碍的 PWID 进行了调查,以确定他们对减少伤害服务的偏好。这项二次分析研究了注射行为偏好、产生这些偏好的原因,以及自我报告的非致命性终身过量用药情况。略多于 56%的参与者更喜欢独自注射,而 44%的参与者更喜欢有人在场时注射,但在这两组中,大多数人大部分时间都是独自注射(97%比 52%,p < 0.01)。普遍报告的独自注射偏好的原因是隐私(82%)和不想被评判(78%),而许多人更喜欢与他人一起注射,以防过量用药(92%)、为了友谊(69%)和分享药物(65%)。那些更喜欢独自注射(而非有人在场时)的人报告称,他们一生中的过量用药次数更高(3.1 次比 2.6 次),但差异没有统计学意义。总之,大多数参与者无论偏好如何,都独自注射。虽然与以前的非致命性过量用药无关,但注射偏好可能会带来未来过量用药的风险。参与者更喜欢独自注射,以避免羞耻或在发生过量用药时与他人一起注射,这可以为支持这两种偏好的公共卫生干预措施提供信息。减少耻辱感的同时促进快速的过量用药反应可以减轻致命过量用药的风险。